Attorney Megan Robertson approaches her practice with enthusiasm that stems both from her personal experiences and her overall passion for the intersection of science, medicine, and the law.
Her background, including an undergraduate degree in genetics, allows her to understand the unique compliance challenges faced by, and the development opportunities available to, companies in the life sciences industry. These include drug and device manufacturers, clinical laboratories, research sponsors, clinical research sites, and contract research organizations (CROs), among others. Megan also coordinates due diligence efforts on behalf of private equity firms to perform risk-based regulatory and compliance assessments of investments in these types of businesses.
Because she has dedicated a substantial portion of her practice to the laboratory industry, Megan is a co-lead of Epstein Becker Green’s Clinical Laboratories Focused Initiative. She regularly advises lab clients and stakeholders on state and federal compliance considerations; in particular, Megan is experienced in guiding clients through the development of direct access testing business models, including aspects such as corporate structure, risk management, and regulatory compliance.
In addition to her life sciences practice, Megan has worked closely with providers of Applied Behavior Analysis (ABA) services to individuals with autism spectrum disorder and previously interned with the advocacy group Autism Speaks. From these experiences, Megan has developed an understanding of the issues related to ABA billing and coding compliance, as well as certain nuances of contracting to provide such services to both private and government payers.
Megan also enjoys working on different pro bono and volunteer initiatives. For example, she is actively involved in Legal Aid DC’s annual Making Justice Real Campaign and represents clients in hearings in front of the Social Security Administration as part of the appeal process to secure disability benefits.
